Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mina Sedrak, MD, MS
City of Hope Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
447 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- City of Hope Corona
Corona, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- City of Hope Mission Hills
Mission Hills, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- City of Hope - Santa Clarita
Santa Clarita, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- City of Hope Upland
Upland, California, United States
- City of Hope West Covina
West Covina, California, United States
- Cancer Center of Colorado at Sloan'S Lake
Denver, Colorado, United States
- Scl Health Saint Joseph Hospital
Denver, Colorado, United States
- Good Samaritan Medical Center
Lafayette, Colorado, United States
- Scl Health Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Delaware Clinical and Laboratory Physicians Pa
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Beebe Health Campus
Rehoboth Beach, Delaware, United States
- Nanticoke Memorial Hospital
Seaford, Delaware, United States
- Christiana Care Health System-Wilmington Hospital
Wilmington, Delaware, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- the Watson Clinic
Lakeland, Florida, United States
- Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Pob Ii
Honolulu, Hawaii, United States
- Hawaii Oncology Inc-Kuakini
Honolulu, Hawaii, United States
- Hawaii Oncology Inc-Pob I
Honolulu, Hawaii, United States
- Island Urology
Honolulu, Hawaii, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2018
- Primary completion
- 8 Sept 2020
- Completion
- 27 Feb 2026
- Last update posted
- 29 Apr 2026
- Registered enrollment
- 93
- Registry id
- NCT03633331
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.